Axis Securities has maintained a 'Buy' rating on Astral Ltd. with a target price of Rs 1,750, citing robust expansion and integration plans. The stock is currently trading at Rs 1,508, implying a potential 16% upside. The report highlights the company's strong Q1 FY27 performance and its shift into newer product categories as key growth areas.
Axis Securities has maintained a positive outlook on Astral Ltd., reiterating a 'Buy' rating with a target price of Rs 1,750 per share. Based on the recent trading price of Rs 1,508, this target reflects a potential upside of approximately 16% for investors. This recommendation comes alongside the company's recent financial results for the first quarter of the 2027 fiscal year, which showed a healthy improvement in both revenue and profitability.
Strong Financial Performance in Q1 FY27
Astral Ltd. recently reported a consolidated revenue of Rs 1,578 crore for the first quarter of fiscal year 2027, marking a 15.9% increase compared to the same period last year. The company also saw a significant jump in its bottom line, with a Profit After Tax (PAT) of Rs 120.2 crore, representing a 51.8% year-on-year growth. This financial performance serves as a foundation for the brokerage's outlook, suggesting that the company is effectively managing its operations despite a challenging economic environment.
Strategic Expansion and Operational Efficiency
The brokerage points to Astral’s strategic move toward backward integration as a major driver for future stability. The company is setting up a facility to produce its own CPVC resin through its subsidiary, Nexelon Chem. By manufacturing this critical raw material in-house, Astral aims to reduce its reliance on external suppliers and protect itself from price swings in the international market, which is often linked to foreign exchange volatility. This initiative is expected to play a crucial role in maintaining profit margins as the company expands its manufacturing footprint.
Furthermore, Astral is aggressively diversifying its product portfolio. While the company is well-known for its piping and plumbing solutions, it has been steadily expanding into adhesives, paints, and bathware. This diversification strategy helps the company reach a wider customer base and reduces its dependence on the performance of a single business segment.
Risks and Market Challenges
While the outlook remains positive, investors should be aware of several risks that could impact the company's growth trajectory. The building materials sector is highly sensitive to the overall health of the housing and infrastructure markets. If demand in these sectors slows down, it could directly impact the company’s volume growth. Additionally, the company faces stiff competition in its newer segments, such as paints and adhesives, where established players have a strong market presence.
Another point of consideration is the raw material environment. Even with backward integration, the company remains exposed to fluctuations in the prices of resins and other petrochemical-based inputs. Investors should also monitor the execution of the company's large spending on expansion projects. Any delays in the commissioning of the new CPVC resin plant, currently expected to be ready by December 2026, or cost overruns could impact financial flexibility. The next key update for investors will be the progress on this production facility and the company's ability to maintain its profit margins while scaling up these new product lines.